HeartBeam Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 16

Employees

  • Stock Symbol
  • BEAT

Stock Symbol

  • Share Price
  • $0.41
  • (As of Thursday Closing)

HeartBeam General Information

Description

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Contact Information

Website
www.heartbeam.com
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Corporate Office
  • 2118 Walsh Avenue
  • Suite 210
  • Santa Clara, CA 95050
  • United States
+1 (408)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Stock Exchange
NAS
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 2118 Walsh Avenue
  • Suite 210
  • Santa Clara, CA 95050
  • United States
+1 (408)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HeartBeam Stock Performance

As of 12-Nov-2026, HeartBeam’s stock price is $0.41. Its current market cap is $25.6M with 63.3M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.41 $0.41 $0.35 - $4.00 $25.6M 63.3M 7.48M -$0.39

HeartBeam Financials Summary

As of 30-Sep-2026, HeartBeam has a trailing 12-month revenue of null.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 11,936 80,809 55,563 42,689
Revenue 0 0 0 0
EBITDA (18,024) (21,097) (19,887) (15,314)
Net Income (18,051) (21,015) (19,448) (14,639)
Total Assets 7,872 5,843 3,276 17,131
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

HeartBeam Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HeartBeam‘s full profile, request access.

Request a free trial

HeartBeam Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG)
Diagnostic Equipment
Santa Clara, CA
16 As of 2026

Tel Aviv, Israel
 

Mountain View, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HeartBeam Competitors (3)

One of HeartBeam’s 3 competitors is SHL Telemedicine, a Formerly VC-backed company based in Tel Aviv, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SHL Telemedicine Formerly VC-backed Tel Aviv, Israel
AliveCor Venture Capital-Backed Mountain View, CA
GE HealthCare Technologies Corporation Chicago, IL
You’re viewing 3 of 3 competitors. Get the full list »

HeartBeam Patents

  • 89

    Total Documents Applications and Grants

  • Total Patents Families

  • 51

    Granted

  • 26

    Pending

  • Expiring in next 12 mo

HeartBeam Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025515444-A A device that generates an electrocardiogram Pending 21-Apr-2022
AU-2023255677-A1 Apparatus for generating an electrocardiogram Pending 21-Apr-2022
EP-4510930-A2 Apparatus for generating an electrocardiogram Pending 21-Apr-2022
EP-4510930-A4 Apparatus for generating an electrocardiogram Pending 21-Apr-2022
US-11529085-B1 Apparatus for generating an electrocardiogram Active 21-Apr-2022 A61B5/332
To view HeartBeam’s complete patent history, request access »

HeartBeam Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HeartBeam ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

38.92 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view HeartBeam’s complete esg history, request access »

HeartBeam FAQs

  • When was HeartBeam founded?

    HeartBeam was founded in 2015.

  • Where is HeartBeam headquartered?

    HeartBeam is headquartered in Santa Clara, CA.

  • What is the size of HeartBeam?

    HeartBeam has 16 total employees.

  • What industry is HeartBeam in?

    HeartBeam’s primary industry is Diagnostic Equipment.

  • Is HeartBeam a private or public company?

    HeartBeam is a Public company.

  • What is HeartBeam’s stock symbol?

    The ticker symbol for HeartBeam is BEAT.

  • What is the current stock price of HeartBeam?

    As of 12-Nov-2026 the stock price of HeartBeam is $0.41.

  • What is the current market cap of HeartBeam?

    The current market capitalization of HeartBeam is $25.6M.

  • Who are HeartBeam’s competitors?

    SHL Telemedicine, AliveCor, and GE HealthCare Technologies are competitors of HeartBeam.

  • What is HeartBeam’s annual earnings per share (EPS)?

    HeartBeam’s EPS for 12 months was -$0.39.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process